Business · 25/09/2012Updated: 10/17/2026 · 1 min read
FDA Releases Guidance on Pre-Storage Leukocyte Reduction of Blood Components
Summary
The Food and Drug Administration (FDA) has released a guidance document providing recommendations for blood establishments on pre-storage leukocyte reduction of whole blood and blood components intended for transfusion, finalizing a draft guidance from 2011 and superseding a 1996 memorandum.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →